The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives

A Huwiler, U Zangemeister-Wittke - Pharmacology & therapeutics, 2018 - Elsevier
The immunomodulatory drug fingolimod (FTY720, Gilenya R) was approved for oral
treatment of relapsing-remitting multiple sclerosis, due to its impressive efficacy and good …

Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2

A Nikolaou, MG Kokotou, S Vasilakaki… - Biochimica et Biophysica …, 2019 - Elsevier
Abstract Phospholipase A 2 (PLA 2) enzymes are involved in various inflammatory
pathological conditions including arthritis, cardiovascular and autoimmune diseases. The …

[HTML][HTML] Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris

S Shao, J Chen, WR Swindell, LC Tsoi, X Xing, F Ma… - JCI insight, 2021 - ncbi.nlm.nih.gov
Altered epidermal differentiation along with increased keratinocyte proliferation is a
characteristic feature of psoriasis and pityriasis rubra pilaris (PRP). However, despite this …

Lure-and-kill macrophage nanoparticles alleviate the severity of experimental acute pancreatitis

Q Zhang, J Zhou, J Zhou, RH Fang, W Gao… - Nature …, 2021 - nature.com
Acute pancreatitis is a disease associated with suffering and high lethality. Although the
disease mechanism is unclear, phospholipase A2 (PLA2) produced by pancreatic acinar …

Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920)

GHM Salvador, AAS Gomes, W Bryan-Quirós… - Scientific Reports, 2019 - nature.com
Abstract The World Health Organization recently listed snakebite envenoming as a
Neglected Tropical Disease, proposing strategies to significantly reduce the global burden …

cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment

S Mishra, M Charan, RK Shukla, P Agarwal… - Journal of Experimental …, 2022 - Springer
Background Molecular mechanisms underlying inflammation-associated breast tumor
growth are poorly studied. S100A7, a pro-inflammatory molecule has been shown to …

Developing small molecule therapeutics for the initial and adjunctive treatment of snakebite

TC Bulfone, SP Samuel, PE Bickler… - Journal of tropical …, 2018 - Wiley Online Library
The World Health Organization (WHO) recently added snakebite envenoming to the priority
list of Neglected Tropical Diseases (NTD). It is thought that~ 75% of mortality following …

The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases

CS Batsika, ADD Gerogiannopoulou… - Expert Opinion on …, 2021 - Taylor & Francis
ABSTRACT Phospholipase A2 (PLA2) enzymes are implicated in several pathological
conditions such as arthritis, cardiovascular diseases, and diabetes. It is highly important to …

Membrane Association Allosterically Regulates Phospholipase A2 Enzymes and Their Specificity

VD Mouchlis, EA Dennis - Accounts of chemical research, 2022 - ACS Publications
Conspectus Water-soluble proteins as well as membrane-bound proteins associate with
membrane surfaces and bind specific lipid molecules in specific sites on the protein …

iPLA2β and its role in male fertility, neurological disorders, metabolic disorders, and inflammation

J Turk, TD White, AJ Nelson, X Lei… - Biochimica et Biophysica …, 2019 - Elsevier
Abstract The Ca 2+-independent phospholipases, designated as group VI iPLA 2 s, also
referred to as PNPLAs due to their shared homology with patatin, include the β, γ, δ, ε, ζ, and …